Physician profile
Peter Rothstein
NPI 1598183543
$30,325.72
in general payments reported to CMS, 2019-2025
27 companies · $1,388 in 2025
The $1,388 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $379 · 2021: $3,889 · 2022: $17K · 2023: $4,340 · 2024: $1,976 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,277 · Travel and Lodging: $2,102 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,276.71 |
| Travel and Lodging | $2,101.59 |
| Education | $325.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,062.64 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $4,797.66 | 2019-2025 | Carto 3, Qdot Micro, Qdot Micro Catheter |
| Abbott Laboratories | $3,754.87 | 2019-2025 | Ensite, Ensite Precision, Cardiomems |
| Boston Scientific Corporation | $3,207.54 | 2019-2025 | Watchman Access System, General - Therapies, Farapulse |
| Pfizer INC. | $459.69 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $349.29 | 2020-2025 | Eliquis, Camzyos |
| Elutia, INC. | $313.18 | 2021 | |
| Amgen INC. | $243.90 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $148.97 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $142.78 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.11 | 2024-2025 | Lifevest |
| Cardiva Medical, INC. | $112.81 | 2021-2022 | |
| Chiesi USA, INC. | $109.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $105.78 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $93.18 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $60.25 | 2019-2020 | |
| Getinge USA Sales, LLC | $52.98 | 2019 | |
| Edwards Lifesciences Corporation | $26.23 | 2019 | |
| Abiomed | $23.22 | 2024 | Impella |
| Astrazeneca Pharmaceuticals Lp | $21.88 | 2024 | Wainua |
| Regeneron Healthcare Solutions, INC. | $21.72 | 2025 | Praluent, Evkeeza |
| Mallinckrodt Hospital Products INC. | $18.94 | 2020 | |
| Impulse Dynamics (USA) INC. | $16.53 | 2022 | |
| Lantheus Medical Imaging, INC. | $15.94 | 2020 | |
| United Therapeutics Corporation | $15.85 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.42 | 2024 | Assure Wcd |
| Teleflex LLC | $13.82 | 2023 | Vascband |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rothstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.